Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Indemnity (GBLI) Asset Writedowns and Impairment (2017 - 2022)

Global Indemnity has reported Asset Writedowns and Impairment over the past 4 years, most recently at $2.0 million for Q4 2021.

  • For Q4 2021, Asset Writedowns and Impairment changed N/A year-over-year to $2.0 million; the TTM value through Dec 2023 reached $2.0 million, changed 0.0%, while the annual FY2022 figure was $508000.0, 74.6% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2021 was $2.0 million at Global Indemnity, up from -$1.9 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $2.0 million in Q4 2021 and troughed at -$1.9 million in Q4 2019.
  • A 4-year average of $546750.0 and a median of $634500.0 in 2017 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 93.21% in 2018 and later crashed 3209.84% in 2019.
  • Year by year, Asset Writedowns and Impairment stood at $898000.0 in 2017, then plummeted by 93.21% to $61000.0 in 2018, then crashed by 3209.84% to -$1.9 million in 2019, then surged by 205.43% to $2.0 million in 2021.
  • Business Quant data shows Asset Writedowns and Impairment for GBLI at $2.0 million in Q4 2021, -$1.9 million in Q4 2019, and $1.9 million in Q1 2019.